Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2005-03-01
2005-03-01
Wehbe′, Anne M. (Department: 1632)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C424S093200, C424S093210, C435S320100, C435S325000, C435S455000
Reexamination Certificate
active
06861414
ABSTRACT:
Methods are provided wherein the survival of an organ transplant is enhanced by introducing into cells of the transplant a nucleic acid molecule that modulates heme oxygenase-I activity therein. Nucleic acid molecules that modulate heme oxygenase-I activity and therefore find use in the described methods include, for example, molecules that encode a polypeptide that itself exhibits heme oxygenase-I activity or antisense oligonucleotides that act to inhibit heme oxygenase-I activity in a cell.
REFERENCES:
patent: 4829984 (1989-05-01), Gordon
patent: 5563132 (1996-10-01), Bodaness
patent: 9609038 (1996-03-01), None
Abraham et al. Intl J Mole Med Apr. 1998; 1 657-63.*
Bowie et al Science Mar. 1990 247 1306-10.*
Boucher et al. J Clin Invest Feb. 1999: 103 441-5.*
Levine et al. Mole Med Today Apr. 1999; 5 165-171.*
Orkin et al. Report of the panel to assess the NIH Investment in research on gene therapy Dec. 1995.*
Rudinger Peptide Hormones 1976: Jun.:pp. 1-7.*
Encyclopedia Britannica online.*
Novogrodsky, A., et al, “Immune Stimulatory Properties of Metalloporphyrins,”The Journal of Immunology, No. 143, 12:3981-3987 (1989).
Weiss, G., et al., “Comparative Effects of Heme and Metalloporphyrins on Interferons-γ-Mediated Pathways in Monocytic Cells (THP-1) (43561),”Proceedings of the Society for Experimental Biology and Medicine, 202, 4:470-475 (1993).
Iyer, S., et al. Characterization and Biological Significance of Immunosuppressive Peptide D2702.75-84 (E → V) Binding Protein,The Journal of Biological Chemistry, No. 273, 5:2692-2697 (1998).
Boasquevisque et al., “Ex Vivo Liposome-Mediated Gene Transfer to Lung Isografts,” J. Thorac. Cardiovasc. Surg. 115(a):38-44 (1998).
Nakamura et al., “Early Biological Effect of In Vivo Gene Transfer of Platelet-Derived Growth Factor (PDGF) -B Into Healing Patellar Ligament,” Gene Therapy, 5:1165-1170 (1998).
Lee et al., “Isolated Lung Liposome-Mediated Gene Transfer Produces Organ-Specific Transgenic Expression,” Ann. Thoracic. Surg. 66(3):903-907 (1998).
Templeton et al., “New Directions in Liposome Gene Delivery,” Molec. Biol. 11(2):175-180 (Apr. 1999).
Muruve et al., “Ex Vivo Adenovirus-Mediated Gene Delivery Leads to Long-Term Expression in Pancreatic Islet Transplants,” Transplantation 64(3):542-546 (1997).
McClane et al., “Functional Consequences of Adenovirus-Mediated Murine Pancreatic Gene Transfer,” Human Gene Ther. 8:739-746 (1997).
Wang et al., “Adenovirus-Mediated Gene Transfer into Rat Cardiac Allografts,” Transplantation, 61(12):1726-1729 (1996).
Brauner et al., J. “Intracoronary Adenovirus-Mediated Transfer of Immunosuppressive Cytokine Genes Prolongs Allograft Survival,” Thorac. Cardiovasc. Surg. 114:923-933 (1977).
Abraham et al., “The Physiological Significance of Heme Oxygenase,”Int. J. Biochem., 20(6):543-558 (1988).
Raju et al., “Coordinated Expression and Mechanism of Induction of HSP32 (heme oxygenase-1) mRNA by Hyperthermia in Rat Organs,”Biochimica et Biophysica Acta, 1217:273-280 (1994).
Neil et al., “Modulation of Corneal Heme Oxygenase Expression by Oxidative Stress Agents,”Journal of Ocular Pharmacology and Therapeutics11(3):455-468 (1995).
Haga et al., “Unconjugated bilirubin inhibits in vitro major histocompatibility complex-unrestricted cytotoxicity of human lymphocytes,”Biochimica et Biophysica Acta1316:29-34 (1996).
Willis et al., “Heme oxygenase: A novel target for the modulation of the inflammatory response,”Nature Medicine2(1):87-90 (1996).
Agarwal et al., “Gas-Generating Systems in Acute Renal Allograft Rejection in the Rat,”Transplantation61:93-98 (1996).
Maines, “Zinc-Protoporphyrin is a Selective Inhibitor of Heme Oxygenase Activity in the Neonatal Rat,”Biochimica et Biophysica Acta673:339-350 (1981).
Drummond et al., “Prevention of neonatal hyperbilirubinemai by tin protoporphyrin IX, a potent competitive inhibitor of heme oxidation,”Proc. Natl. Acad. Sci. USA78(10):6466-6470 (1981).
Tenhunen et al., “Microsomal Heme Oxygenase,”The Journal of Biological Chemistry244(23):6388-6394 (1969).
Sinal et al., “Liver transplantation induces cytochrome P450 1A1dependent Monooxygenase activity in rat lung and kidney,”Canadian Journal of Physiology and Pharmacology73:146-152 (1995).
Martasek et al., “Properties of Human Kidney Heme Oxygenase: Inhibition by Synthetic Heme Analogues and Metalloporphyrins,”Biochemical and Biophysical Research Communications157(2):480-487 (1988).
Dorland's Illustrated Medical Dictionary (W.B. Saunders & Co., Philadelphia, PA) 600 (1988).
Crystal, R.G. Science. 270:404-410 (1995).
Ledley, F.D. Parmaceutical Review. 13:1595-1613 (1996).
Miller et al., FASEB J. 9:190-199 (1995).
Eck et al. Chapter 5. Goodman and Gilaman' The Pharmacological Basis of Therapeutics. 9th ed. McGraw Hill. 77-101 (1995).
Verma et al. Nature. 389:239-242 (1997).
Cuturi et al., “RDP1258, a New Rationally Designed Immunosuppressive Peptide, Prolong Allograft Survival in Rats: Analysis of Its Mechanism of Action,” Molecular Medicine 5:820-832 (1999).
Soares et al., “Expression of heme oxygenase-1 can determine cardiac xenograft survival,” Nature Medicine, 4(9):1073-1077 (1998).
Otterbein et al., “Carbon monoxide had anti-inflammatory effects involving the mitogen-activated protein kinase pathway,” Nature Medicine, 6(4): 422-428 (2000).
Woo et al., “Alleviation of graft-versus-host disease after conditioning with cobalt-protoporphyrin, and inducer of heme oxygenase-1,” Transplantation, 69(4): 623-633 (2000).
DeBruyne et al., “Gene transfer of immunomodulatory peptides correlates with heme oxygenase-1 induction and enhanced Allograft survival,” Transplantation, 69(1): 120-128 (2000).
Amersi et al., “Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injury,” The Journal of Clinical Investigation, 104(11): 1631-1639 (1999).
Evans, C-O et al., “Cloning and sequencing and expression of cDNA for chick liver haem oxygenase: comparison of avian and mammalian cDNAs and deduced protein,”Biochem J. 273:659-666 (1991).
Yoshida, et al., “Human heme oxygenase cDNA and induction of its mRNA by hemin,”Eur. J. Biochem. 171:457-461 (1988).
Ishikawa, K. et al., “Expression of rat heme oxygenase inEscherichia colias a catalytically active, full length form that binds to bacterial membranes,”Eur. J. Biochem. 202:161-165 (1991).
Schmitt, M.P., Utilization of Host Iron Sources by Corynebacterium diphtheriae: Identification of a Gene Whose Product Is Homologous to Eukaryotic Heme Oxygenases and Is Required for Acquisition of Iron from Heme and Hemoglobin,J. Bact. 179(5):838-845 (1997).
Rotenberg, M.O. et al., “Characterization of a cDNA-Encoding Rabbit Brain Heme Oxygenase-2 and Identification of a conserved Domain among Mammalian Heme Oxygenase Isozymes: Possible Heme-Binding Site,”Archive Biochem. Biophy. 290(2) 336-344 (1991).
Wilks, A. et al., “Rat Liver Heme Oxygenase: High Level Expression of a Truncated Soluble Form and Nature of the Meso-Hydroxylating Species,”J. Biol. Chem. 268:22357-62 (1993).
Schuller, D,J, “Crystal structure of heme oxygenase-1,”Nature Struct. Biol. 6(9):860-867 (1999).
Omata, Y. et al., “Crystallization and preliminary X-ray diffraction studies on the water soluble form of rat heme oxygenase-1 in complex with heme,”Acta. Cryst. D54:1017-1019 (1998).
Hegazy, K.A. et al., “Functional human heme oxygenase has a neuroprotective effect on adult rat ganglion cells after pressure induces Ischemia,”Regeneration and Transplantation11(6):1185-1189 (2000).
Melo, L.G. et al., “Gene Therapy strategy for Long-Term Myocardial Protection Using Adeno-Associated Virus Med
Buelow Roland
Iyer Suhasini
Woo Jacky
Dorsey & Whitney LLP
Li Q. Janice
Lorenz Todd A.
Oh Charlie Y.
Sangstat Medical Corporation
LandOfFree
Methods for enhancing graft survival by modulating heme... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for enhancing graft survival by modulating heme..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for enhancing graft survival by modulating heme... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3418548